JPS539227B2 - - Google Patents
Info
- Publication number
- JPS539227B2 JPS539227B2 JP744192A JP419274A JPS539227B2 JP S539227 B2 JPS539227 B2 JP S539227B2 JP 744192 A JP744192 A JP 744192A JP 419274 A JP419274 A JP 419274A JP S539227 B2 JPS539227 B2 JP S539227B2
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/32—Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Priority Applications (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP744192A JPS539227B2 (US06858664-20050222-C00036.png) | 1973-12-26 | 1973-12-26 | |
| FI366374A FI59584C (fi) | 1973-12-26 | 1974-12-18 | Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-(1-hydroxi-aminoalkyl)-karbostyril- eller 3,4-dihydrokarbostyrilderivat |
| DK661674A DK138890C (da) | 1973-12-26 | 1974-12-18 | Analogifremgangsmaade til fremstilling af et carbostyril- eller 3,4-dihydrocarbostyrilderivat eller syreadditionssalte deraf |
| AR25706174A AR210729A1 (US06858664-20050222-C00036.png) | 1973-12-26 | 1974-12-23 | |
| NO744666A NO144964C (no) | 1973-12-26 | 1974-12-23 | Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyril- eller 3,4-dihydrokarbostyrilderivater |
| ES433573A ES433573A1 (es) | 1973-12-26 | 1974-12-24 | Procedimiento para preparar derivados carbostirilicos. |
| CH1727674A CH601244A5 (en) | 1973-12-26 | 1974-12-24 | Carbostyryl and 3,4-dihydro carbostyryl derivs. |
| BE151913A BE823841A (fr) | 1973-12-26 | 1974-12-24 | Derives de 5-(1-hydroxy-2-amino substitue) alkyl-8-carbostyryle substitue et de 5-(1-hydroxy-2-amino substitue) alkyl-8-(3,4-dihydro) carbostyryle substitue et leur procede de preparation |
| SU742104656A SU670219A3 (ru) | 1973-12-26 | 1974-12-25 | Способ получени карбостирил-или-3,4дигидрокарбостирил-производных |
| US05/536,704 US3975391A (en) | 1973-12-26 | 1974-12-26 | 5-[1-Hydroxy-2-(substituted-amino)]ethyl-8-hydroxy-3,4-dihydrocarbostyril derivatives |
| KR7404368A KR790000220B1 (en) | 1973-12-26 | 1974-12-26 | Process for preparing 5-(1-hydroxy-2-substituted-amino)alkyl-8-substituted-carbostyril (or-3,4-dihydro carbostril) derivatives |
| FR7442897A FR2255905A1 (en) | 1973-12-26 | 1974-12-26 | Carbostyryl and 3,4-dihydro-carbostyryl derivs. - bronchodilators, vasodilators and antihypertensives, esp. useful against bronchial asthma |
| GB5589974A GB1496768A (en) | 1973-12-26 | 1974-12-27 | 5-substituted ethyl-8-hydroxycarbostyril derivatives and production thereof |
| GB2886277A GB1496873A (en) | 1973-12-26 | 1974-12-27 | 5-substituted aminoacetyl-8-hydroxy-or-alkoxycarbostyrils and production thereof |
| DE19742461604 DE2461604A1 (de) | 1973-12-26 | 1974-12-27 | 8-hydroxy-3,4-dihydrocarbostyril- derivate, verfahren zu ihrer herstellung und arzneimittel |
| HK197/81A HK19781A (en) | 1973-12-26 | 1981-05-14 | Kyoto |
| MY8200092A MY8200092A (en) | 1973-12-26 | 1982-12-31 | 5-substituted ethyl-8-hydrocarbostyril derivatives and production thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP744192A JPS539227B2 (US06858664-20050222-C00036.png) | 1973-12-26 | 1973-12-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5095279A JPS5095279A (US06858664-20050222-C00036.png) | 1975-07-29 |
| JPS539227B2 true JPS539227B2 (US06858664-20050222-C00036.png) | 1978-04-04 |
Family
ID=11577822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP744192A Expired JPS539227B2 (US06858664-20050222-C00036.png) | 1973-12-26 | 1973-12-26 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS539227B2 (US06858664-20050222-C00036.png) |
| BE (1) | BE823841A (US06858664-20050222-C00036.png) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH023710Y2 (US06858664-20050222-C00036.png) * | 1985-01-21 | 1990-01-29 |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS539232B2 (US06858664-20050222-C00036.png) * | 1974-02-27 | 1978-04-04 | ||
| JPS5283380A (en) * | 1975-12-26 | 1977-07-12 | Otsuka Pharmaceut Co Ltd | Synthesis of thiocarbostyril derivatives |
| JPS609713B2 (ja) * | 1976-10-08 | 1985-03-12 | 大塚製薬株式会社 | カルボスチリル誘導体 |
| US4314944A (en) | 1980-08-22 | 1982-02-09 | Smithkline Corporation | 4-Aminoalkyl-7-hydroxy-2(3H)-indolones |
| EP0355583B1 (en) * | 1988-08-10 | 1995-01-25 | Otsuka Pharmaceutical Co., Ltd. | Cardiotonics |
| WO2013115793A1 (en) * | 2012-01-31 | 2013-08-08 | Varinel, Inc. | Iron chelators and uses thereof |
| US9784726B2 (en) | 2013-01-08 | 2017-10-10 | Atrogi Ab | Screening method, a kit, a method of treatment and a compound for use in a method of treatment |
| GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
| WO2024153813A1 (en) | 2023-01-20 | 2024-07-25 | Atrogi Ab | Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting |
| GB202302225D0 (en) | 2023-02-16 | 2023-04-05 | Atrogi Ab | New medical uses |
| GB202303229D0 (en) | 2023-03-06 | 2023-04-19 | Atrogi Ab | New medical uses |
-
1973
- 1973-12-26 JP JP744192A patent/JPS539227B2/ja not_active Expired
-
1974
- 1974-12-24 BE BE151913A patent/BE823841A/fr active Protection Beyond IP Right Term
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH023710Y2 (US06858664-20050222-C00036.png) * | 1985-01-21 | 1990-01-29 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5095279A (US06858664-20050222-C00036.png) | 1975-07-29 |
| BE823841A (fr) | 1975-04-16 |
